Washington, DC, United States of America

William Matthew Dickerson

This inventor holds 7 USPTO granted patents and 14 published patent applications, plus 1 CIPO patent. Top assignee: Cellphire, Inc.. Active years: 2023-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: William Matthew Dickerson. Retrieved from https://idiyas.com/inventor/william-matthew-dickerson-eu3hvmcd

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 7 

% Patents Active = 100.0

 

Average Co-Inventor Count = 6.5

ph-index = 2

Forward Citations = 15(Granted Patents)


Company Filing History:


Years Active: 2023-2025

Loading Chart...
Loading Chart...
7 patents (USPTO):Explore Patents

Title: Innovations of William Matthew Dickerson

Introduction

William Matthew Dickerson is a prominent inventor based in Washington, DC, known for his significant contributions to the field of medical technology. With a total of seven patents to his name, he has made remarkable advancements in the treatment of coagulopathy and antiplatelet therapy. His work is characterized by innovative methods and compositions that enhance patient care.

Latest Patents

Among his latest patents is a groundbreaking method titled "Thrombosomes as an antiplatelet agent reversal agent." This invention outlines a method for treating coagulopathy by administering a composition that includes platelets or platelet derivatives along with an incubating agent. The method aims to effectively reverse the effects of antiplatelet agents in patients. Another notable patent is "Platelet derivative compositions, and pluralities of containers containing same," which provides methods and compositions for treating coagulopathy, particularly in subjects who have been administered anticoagulant agents. These patents reflect his commitment to improving medical treatments and patient outcomes.

Career Highlights

William Matthew Dickerson has established himself as a key figure in the medical technology sector. His work at Cellphire, Inc. has been instrumental in developing innovative solutions for blood-related medical conditions. His expertise and dedication have led to significant advancements in the field, making him a respected inventor among his peers.

Collaborations

Throughout his career, Dickerson has collaborated with notable colleagues, including Keith Andrew Moskowitz and Braden Carl Ishler. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

William Matthew Dickerson's contributions to medical technology through his patents and collaborations highlight his role as a leading inventor in the field. His innovative approaches to treating coagulopathy and enhancing patient care continue to make a significant impact.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…